University of California, San Diego (UCSD) Medical Center

San Diego, California 92103

3 studies enrolling now · 6 studies all time

What they study most

Liver Cirrhosis, Multiple Myeloma, Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Pulmonary Embolism, Symptomatic Genetic Dilated Cardiomyopathy, Thrombotic Disease, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Trauma, Vascular System Injury

Studies at this site

• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
• Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma — Completed
• Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism — Completed
• Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis — Stopped early